Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development Transcript
Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development October 27, 2026 8:00 AM EDT Abigail Lee Gray - Director of Investor RelationsLeon Moulder - Founder, CEO & ChairmanHaley Laken - Chief Scientific OfficerLisa von Moltke - Head of Research & Development and Chief Medical Officer…